Lonza Group AG

Lonza Group AG

LONN · SW · Healthcare / Diagnostics & Research

603.8CHF+18.40 (+3.14%)

Price History

Full chart

Market Stats

Previous Close585.4
Open593.4
Day Range588.4 – 608.4
52-Week Range449.88 – 597.8
Volume225.54K
Market Cap39.50B
P/E (TTM)36.49
Forward P/E25.06
EPS15.5
Dividend Yield0.88%
Beta0.84
50-Day Avg566.43
200-Day Avg530.75

About

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEODr. Wolfgang Wienand Ph.D.
  • Employees20.14K
  • HeadquartersMuenchensteinerstrasse 38, Basel, Switzerland, 4002, Switzerland
  • Websitehttps://www.lonza.com

Leadership

  • Dr. Wolfgang Wienand Ph.D.Chief Executive Officer · b. 1972
  • Mr. Philippe DeeckeChief Financial Officer
  • Mr. Jason BerndtExecutive VP & Head of Group Operations
  • Mr. Daniel BuchtaHead of Investor Relations
  • Mr. Andreas BohrerChief Legal & Corporate Affairs Officer
  • Ms. Kim HarrelsonHead of Ethics & Compliance, ERM and Corporate Responsibility
  • Mr. Hans TreesSenior VP & Global Head of Communications
  • Ms. Jennifer ClancySenior Director of Global Marketing
  • Ms. Nicoleta BaumgartnerChief Human Resources Officer · b. 1971
  • Dr. Matthias HofmannHead of Corporate Environment, Health, Safety & Global Sustainability

Financials

Income Statement

Line item2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.18B1.89B2.29B2.87B2.94B2.69B2.68B2.69B3.92B3.58B3.64B3.80B4.13B4.55B5.54B4.21B4.51B5.41B6.22B6.72B5.48B6.53B
Cost of Revenue1.72B191.00M213.00M2.04B2.10B2.04B1.95B1.94B2.87B2.58B2.51B2.61B2.70B2.92B3.52B2.59B2.80B3.44B3.92B4.90B3.51B4.23B
Gross Profit464.00M1.70B2.07B833.00M839.00M648.00M726.00M749.00M1.05B1.00B1.13B1.19B1.43B1.63B2.02B1.62B1.71B1.97B2.30B1.82B1.97B2.30B
Operating Income173.00M218.00M254.00M352.00M354.00M244.00M283.00M219.00M380.00M422.00M455.00M505.00M546.00M688.00M946.00M847.00M937.00M819.00M1.35B854.00M1.09B1.38B
EBITDA388.00M427.00M442.00M603.00M604.00M522.00M556.00M495.00M684.00M731.00M754.00M805.00M853.00M1.10B1.47B1.39B1.46B1.34B1.95B1.48B1.56B2.03B
Net Income138.00M188.00M199.00M301.00M420.00M162.00M291.00M154.00M174.00M87.00M237.00M277.00M301.00M707.00M559.00M756.00M869.00M2.94B1.22B654.00M636.00M-275.00M
R&D71.00M54.00M70.00M89.00M110.00M96.00M141.00M171.00M215.00M214.00M195.00M185.00M144.00M150.00M160.00M76.00M78.00M90.00M95.00M105.00M102.00M112.00M
Interest Expense36.00M66.00M55.00M72.00M82.00M54.00M40.00M49.00M118.00M108.00M84.00M87.00M85.00M130.00M101.00M84.00M71.00M72.00M73.00M108.00M145.00M167.00M

Balance Sheet

Line item2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.34B4.33B3.91B4.95B4.93B4.94B4.78B7.02B7.10B6.37B6.44B6.25B6.83B13.83B13.92B13.84B14.63B16.46B17.36B16.85B19.73B18.97B
Total Liabilities2.06B2.84B2.31B3.14B3.14B2.56B2.39B4.66B4.69B4.25B4.31B4.11B4.47B7.65B7.63B7.28B7.74B6.64B6.69B7.34B10.35B9.78B
Total Equity1.28B1.49B1.61B1.81B1.79B2.33B2.39B2.36B2.41B2.13B2.13B2.13B2.35B6.13B6.22B6.49B6.82B9.75B10.60B9.45B9.33B9.13B
Cash40.00M646.00M217.00M372.00M372.00M140.00M248.00M196.00M429.00M306.00M209.00M277.00M274.00M479.00M461.00M505.00M495.00M1.58B1.34B1.47B1.11B719.00M
Total Debt1.09B1.63B1.16B1.71B1.71B1.49B1.46B2.93B2.81B2.48B2.22B1.94B1.86B4.25B4.06B3.78B3.81B2.75B2.59B3.13B5.12B4.54B
Net Debt1.05B980.00M938.00M1.34B1.34B1.35B1.21B2.73B2.39B2.17B2.01B1.66B1.59B3.77B3.60B3.28B3.32B1.17B1.25B1.66B4.01B3.82B

Cash Flow

Line item2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow178.00M413.00M425.00M644.00M175.00M422.00M502.00M221.00M710.00M522.00M483.00M741.00M752.00M841.00M1.08B986.00M1.13B1.22B1.02B1.39B1.27B1.17B
Investing Cash Flow-200.00M-221.00M-373.00M-1.05B-545.00M-446.00M-358.00M-1.19B-282.00M-187.00M-167.00M-282.00M-601.00M-3.75B-652.00M-285.00M-1.09B1.02B-974.00M-1.10B-2.92B-732.00M
Financing Cash Flow18.00M411.00M-480.00M572.00M578.00M-404.00M-30.00M923.00M-192.00M-451.00M-421.00M-381.00M-151.00M3.20B-413.00M-672.00M93.00M-1.28B-284.00M-152.00M1.28B-755.00M
Capital Expenditure229.00M226.00M345.00M588.00M648.00M520.00M300.00M272.00M310.00M194.00M158.00M256.00M355.00M420.00M528.00M807.00M973.00M1.34B1.87B1.65B1.42B1.37B
Free Cash Flow-51.00M187.00M80.00M56.00M-473.00M-98.00M202.00M-51.00M400.00M328.00M325.00M485.00M397.00M421.00M554.00M179.00M157.00M-124.00M-852.00M-263.00M-143.00M-204.00M
Dividends Paid62.00M62.00M61.00M72.00M83.00M87.00M92.00M111.00M111.00M112.00M112.00M131.00M131.00M160.00M206.00M206.00M206.00M225.00M228.00M260.00M288.00M280.00M

Earnings

Report DateJul 29, 2005Jan 23, 2014Jul 24, 2014Jan 21, 2015Jul 22, 2015Jan 27, 2016Jul 20, 2016Jan 25, 2017Apr 26, 2017Jan 31, 2018May 4, 2018Jul 25, 2018Jan 30, 2019Jul 24, 2019Jan 21, 2020May 8, 2020Jul 23, 2020Oct 20, 2020Jan 26, 2021Apr 22, 2021Jul 23, 2021Oct 26, 2021Feb 1, 2022Apr 21, 2022Jul 22, 2022Oct 25, 2022Jan 25, 2023Apr 20, 2023Jul 21, 2023Oct 24, 2023Jan 26, 2024May 14, 2024Jul 25, 2024Nov 29, 2024Apr 3, 2025Jul 23, 2025Nov 28, 2025Apr 16, 2026Jan 27, 2027
EPS Estimate1.662.290.002.822.530.003.600.000.005.090.004.175.876.235.830.006.090.006.420.006.180.006.680.007.320.008.590.008.328.448.960.009.660.0010.40-0.000.00-
EPS Actual0.740.000.000.000.002.913.431.860.006.550.005.393.385.264.960.006.390.003.380.003.500.005.550.006.660.0016.340.000.000.000.000.000.000.004.316.070.000.00-
Surprise-55.42%-100.00%--100.00%-100.00%--4.72%--28.68%-29.26%-42.42%-15.57%-14.92%-4.93%--47.35%--43.37%--16.92%--9.02%-90.22%--100.00%-100.00%-100.00%--100.00%--58.56%----
TimingAfter-hours-----------------------Pre-market-Pre-market-Pre-market--After-hours---After-hours--Pre-market

Key Statistics & Ratios

Market Cap39.50B
Enterprise Value42.92B
Trailing P/E36.49
Forward P/E25.06
PEG Ratio1.01
Price / Sales5.75
Price / Book4.83
EPS15.5
Book Value116.37
Revenue (TTM)6.87B
Gross Profit (TTM)2.55B
EBITDA2.39B
Profit Margin-1.60%
Operating Margin23.41%
Return on Equity12.90%
Return on Assets5.44%
Shares Outstanding69.84M
Shares Float69.74M
Beta0.84
Dividend Yield0.88%
Dividend Rate5
Payout Ratio32.28%

Dividends

20261×
5.00May 12, 2026
20251×
4.00May 13, 2025
20241×
4.00May 13, 2024
20231×
3.50May 9, 2023
20221×
3.00May 9, 2022
20211×
3.00May 10, 2021
20201×
2.75Apr 30, 2020
20191×
2.75Apr 24, 2019
20181×
2.75May 8, 2018
20171×
2.75Apr 27, 2017
20161×
2.32Apr 26, 2016
20151×
2.32Apr 10, 2015
20141×
1.99Apr 22, 2014
20131×
1.99Apr 11, 2013
20121×
1.99Apr 5, 2012
20111×
1.99Apr 14, 2011
20101×
1.62Apr 7, 2010
20091×
1.62Apr 16, 2009
20081×
1.62Apr 1, 2008
20071×
1.39Apr 3, 2007
20061×
1.20Mar 28, 2006
20051×
1.20Apr 15, 2005
20041×
1.20Apr 6, 2004
20031×
1.76Apr 1, 2003

Stock Splits

  • May 2, 2017407:377
  • Apr 3, 200210:1